Showing results (1711-1720 of 3,392) with videos related to

Sort By:
Pageof 340
Nature Genetics|January 15, 2002
Angptl3 regulates lipid metabolism in miceRyuta Koishi, Yosuke Ando, Mitsuru Ono, et al.
The Journal of Toxicological Sciences|June 9, 2000
Toxicity and blood concentrations of xylazine and its metabolite, 2,6-dimethylaniline, in rats after single or continuous oral administrationsK Yasuhara, H Kobayashi, Y Shimamura, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2002
Functional human T lymphocyte development from cord blood CD34+ cells in nonobese diabetic/Shi-scid, IL-2 receptor gamma null miceTakashi Yahata, Kiyoshi Ando, Yoshihiko Nakamura, et al.
Surgery Today|November 4, 2000
Key factors influencing bowel function after ileal W-pouch anal anastomosis: a spectral analysis of W-pouch motor activityT Maruta, S Homma, M Yagi, et al.
Journal of Neurology|July 15, 2000
Visual event-related potentials in progressive supranuclear palsy, corticobasal degeneration, striatonigral degeneration, and Parkinson's diseaseL Wang, Y Kuroiwa, T Kamitani, et al.
Surgical Case Reports|December 14, 2019
Complete resection of local advanced thymic carcinoma with total aortic arch replacement after chemotherapy: a case reportHidenori Kuno, Soichiro Funaki, Kenji Kimura, et al.
The Journal of Veterinary Medical Science|April 7, 2006
Effect of intermittent administration of sustained release isosorbide dinitrate (sr-ISDN) in rats with pressure-overload heartShunsuke Shimamura, Hayato Endo, Hiromi Kutsuna, et al.
Journal of Computer Assisted Tomography|March 1, 1992
Focal nodular hyperplasia of the liver: arterial angio-CT and microangiographyK Takayasu, Y Muramatsu, N Moriyama, et al.
The Journal of Antibiotics|May 1, 1993
Inhibition of angiogenesis by erbstatin, an inhibitor of tyrosine kinaseT Oikawa, H Ashino, M Shimamura, et al.
Chemical & Pharmaceutical Bulletin|January 1, 1995
Studies on antiulcer agents. I. Synthesis and pharmacological properties of ethyl 2-[(1H-benzimidazol-2-yl)sulfinylmethyl]-4-dimethylamino-5- pyrimidinecarboxylate, a new H+/K(+)-ATPase inhibitor possessing mucosal protective activityK Terashima, H Shimamura, A Kawase, et al.
Pageof 340